Purchase addrall online in the UK
Adzenys XR-ODT: Uses, Dosage, Side Effects, and Safety Guide

Adzenys XR-ODT solves a specific, common problem: some children and adults with ADHD struggle to swallow capsules, and this tablet doesn’t require that at all. Because it’s engineered to dissolve directly on the tongue, patients don’t need water to take it. Beyond that delivery difference, it works through the same amphetamine mechanism as other stimulants in this series, and it carries the same Schedule II status and controlled-substance responsibilities.

The information below reflects current FDA prescribing information for Adzenys XR-ODT. It’s meant for general education, so it doesn’t replace advice from a licensed prescriber or pharmacist.

Product Overview

What Is Adzenys XR-ODT?

Adzenys XR-ODT delivers amphetamine in an extended-release, orally disintegrating tablet — meaning it dissolves in saliva rather than requiring a swallow. Because the tablet combines roughly equal parts immediate-release and delayed-release amphetamine, it supports once-daily dosing similar to other extended-release stimulants, while offering an administration method that works for patients who can’t or won’t swallow pills.

Active Ingredient

The active ingredient is amphetamine, formulated as a 3:1 ratio of dextro- to levo-amphetamine base. Because Adzenys XR-ODT measures its strength in terms of amphetamine base rather than amphetamine salt weight, its milligram numbers don’t directly match those of salt-based products like Adderall XR, even at a comparable clinical dose.

Brand Name and Generic Name

Neos Therapeutics Brands, LLC holds the labeling for Adzenys XR-ODT. As of this writing, no generic version has reached the market, though that can change over time.

Drug Classification

Adzenys XR-ODT belongs to the amphetamine class of CNS stimulants. Consequently, the DEA classifies it as a Schedule II controlled substance.

FDA-Approved Uses

Adzenys XR-ODT is approved for one condition:

• Attention deficit hyperactivity disorder (ADHD) in patients 6 years of age and older.

Because children younger than 6 showed higher drug exposure and more side effects, including weight loss, at the same dose in related trials, the label doesn’t recommend it for that age group. It also hasn’t been studied specifically in the geriatric population.

Evidence-Supported Off-Label Uses

As with other amphetamine-based stimulants, some clinicians consider off-label use for conditions like treatment-resistant depression augmentation, though this falls outside the approved indication and should only happen under a prescriber’s individualized judgment.

How It Works

Amphetamines block the reuptake of norepinephrine and dopamine into the presynaptic neuron and increase the release of these chemicals into the surrounding space. The exact mechanism behind the resulting ADHD benefit hasn’t been fully defined, though this increased signaling is thought to improve attention, focus, and impulse control.

Product Information Table

Available Strengths

Every strength looks identical in color, so the debossed number is what actually distinguishes them — worth double-checking at each refill.

Because all six strengths share the same color, patients and caregivers should confirm the imprint number rather than relying on appearance alone.

Dosage Guide

Because Adzenys XR-ODT measures amphetamine base rather than salt weight, its numbers won’t match milligram-for-milligram with Adderall XR, even though a conversion between the two exists.

Children and Adolescents (6 to 17 Years)

Treatment starts at 6.3 mg once daily in the morning. The dose may be increased in 3.1 mg or 6.3 mg increments at weekly intervals, based on response and tolerability. The maximum recommended dose is 18.8 mg daily for children ages 6 to 12, and 12.5 mg daily for adolescents ages 13 to 17.

Switching From Adderall XR

Patients already stabilized on Adderall XR can switch to an equivalent dose of Adzenys XR-ODT taken once daily, following a conversion table in the prescribing information. As one reference point, a single 18.8 mg dose of Adzenys XR-ODT produces a comparable plasma concentration profile to a 30 mg dose of mixed amphetamine salts extended-release capsules. Because the conversion isn’t a simple like-for-like number match, a prescriber should guide any switch rather than a patient estimating it independently.

Older Adults

Adzenys XR-ODT hasn’t been studied in the geriatric population, so this age group falls outside its established evidence base.

Kidney and Liver Function

The label doesn’t provide a specific dosing table for kidney or liver impairment. Because amphetamine elimination depends partly on urinary pH and partly on liver metabolism, both kidney and liver dysfunction have the potential to prolong drug exposure, so a prescriber should know about any significant impairment before starting treatment.

How to Take It

Using the Orally Disintegrating Tablet

The tablet should stay in its blister pack until the moment it’s taken. With dry hands, the patient or caregiver tears along the perforation, bends the blister as indicated, and peels back the backing — the tablet should never be pushed through the foil, since that can damage it. Once removed, the tablet goes directly on the tongue and dissolves in saliva without chewing or crushing, then gets swallowed naturally.

With or Without Food

Adzenys XR-ODT can be taken with or without food, based on individual preference and response.

Missed Dose

If a morning dose is missed, it generally shouldn’t be taken later in the day, since doing so raises the risk of insomnia. Patients should skip the missed dose and resume their normal schedule the next morning unless their prescriber advises otherwise.

Overdose

Amphetamine overdose can cause dangerously high blood pressure, rapid heartbeat, high body temperature, agitation, hallucinations, or seizures. Anyone who suspects an overdose should call Poison Control at 1-800-222-1222 or go to the nearest emergency room immediately.

Storage and Disposal

Adzenys XR-ODT should be stored in its blister packaging, in a secure, ideally locked, location. For disposal, a DEA-authorized take-back program is preferred; alternatively, mixing unused tablets with an undesirable substance like coffee grounds before sealing and discarding them in household trash is an accepted method.

Benefits

For patients who struggle to swallow capsules or tablets — a common issue in younger children, but not exclusive to them — Adzenys XR-ODT offers a genuine alternative delivery method without switching to a liquid formulation. Because it uses the same 3:1 amphetamine ratio as other well-established stimulants, prescribers can draw on a broad evidence base for the underlying medication even though the tablet format itself is newer.

Side Effects

Stimulant medications affect multiple body systems, so side effects range from mild to serious.

Common Side Effects

• Decreased appetite
• Insomnia
• Weight loss
• Headache
• Irritability
• Dry mouth
• Nausea
• Nervousness

Less Common Side Effects

• Dizziness
• Increased heart rate
• Abdominal pain
• Anxiety

Serious Side Effects

• New or worsening mental health symptoms, including mania or psychosis
• Slowed growth in children
• Circulation problems in fingers or toes (Raynaud’s phenomenon)
• Seizures
• New or worsening tics
• Serotonin syndrome (when combined with certain other medications)

Emergency Symptoms

Patients should seek emergency care immediately for:

• Chest pain, shortness of breath, or fainting
• Signs of serotonin syndrome, such as agitation, high fever, or muscle rigidity
• Unexplained wounds appearing on fingers or toes
• Signs of a severe allergic reaction, such as facial or throat swelling

Drug Interactions

Because amphetamines affect the heart and nervous system, Adzenys XR-ODT interacts with several other substances.

Prescription Drugs

Combining Adzenys XR-ODT with monoamine oxidase inhibitors (MAOIs) is contraindicated due to the risk of hypertensive crisis. Serotonergic medications, tricyclic antidepressants, and CYP2D6 inhibitors can each raise the risk of serotonin syndrome or increase amphetamine exposure, potentially requiring a dose adjustment.

OTC Medicines

Alkalinizing agents, such as some antacids, increase amphetamine blood levels, while acidifying agents lower them. Decongestants and other stimulant-containing OTC products can add cardiovascular strain when combined with Adzenys XR-ODT.

Alcohol

The label doesn’t detail a specific dose-release interaction between alcohol and this tablet formulation, but alcohol can still add cardiovascular strain when combined with any stimulant, so patients should discuss alcohol use with their prescriber.

Supplements

St. John’s Wort raises the risk of serotonin syndrome when combined with amphetamine products. Patients should disclose all supplement use to their prescriber.

Herbal Products

As with St. John’s Wort above, herbal products with serotonergic or stimulant-like activity should be discussed with a prescriber before combining with Adzenys XR-ODT.

Foods

No major food restriction applies, though acidic foods and juices can modestly reduce amphetamine absorption through the same mechanism as acidifying medications.

Warnings

Adzenys XR-ODT carries an FDA boxed warning for abuse, misuse, and addiction. Misuse — including taking higher doses, using it without a prescription, or altering the route of administration — increases the risk of overdose and death.

The medication also carries warnings for sudden death in patients with underlying heart conditions, increased blood pressure and heart rate, new psychiatric symptoms, growth suppression in children, peripheral vasculopathy, seizures, and serotonin syndrome.

Contraindications

Adzenys XR-ODT should not be used by patients who:

• Have a known hypersensitivity to amphetamine or other ingredients in Adzenys XR-ODT
• Are taking, or have taken within the past 14 days, a monoamine oxidase inhibitor (MAOI), including linezolid or intravenous methylene blue

Pregnancy

Available data from decades of epidemiologic studies and postmarketing reports on amphetamine use in pregnant women haven’t identified a clear drug-associated risk of major birth defects or miscarriage. Even so, amphetamines cause vasoconstriction that may decrease placental blood flow, and infants exposed in utero face a risk of withdrawal symptoms after delivery. A pregnancy exposure registry tracks outcomes for people exposed to ADHD medications, including Adzenys XR-ODT, during pregnancy.

Breastfeeding

Amphetamine passes into human milk at meaningful levels, and the current label specifically advises against breastfeeding during Adzenys XR-ODT treatment, given the potential for serious effects in a nursing infant.

Monitoring Requirements

Prescribers typically monitor the following throughout treatment:

• Blood pressure and heart rate at each visit
• Height and weight, checked often in pediatric patients
• Signs of new or worsening psychiatric symptoms
• Signs of misuse, dependence, or diversion
• Family and personal history of tics or Tourette’s syndrome before starting

Storage Instructions

Adzenys XR-ODT should be kept at room temperature, between 68°F and 77°F (20°C to 25°C), in its original blister packaging. Patients should store it in a secure, ideally locked, location and never share it with anyone else, since doing so is both dangerous and illegal.

Frequently Asked Questions

What is Adzenys XR-ODT used for?

Adzenys XR-ODT is FDA-approved to treat attention deficit hyperactivity disorder (ADHD) in patients 6 years of age and older. Because it dissolves on the tongue rather than requiring a swallow, it’s often chosen for patients who have difficulty taking traditional capsules or tablets.

How is Adzenys XR-ODT different from Adderall XR?

Both contain amphetamine in the same 3:1 dextro-to-levo ratio, but Adzenys XR-ODT dissolves on the tongue instead of being swallowed as a capsule, and its strength is measured in amphetamine base rather than amphetamine salt. Because of this different measurement system, the milligram numbers between the two products don’t match directly, even at clinically equivalent doses.

What is the typical starting dose of Adzenys XR-ODT?

For patients 6 to 17, treatment starts at 6.3 mg once daily in the morning, increasing in 3.1 mg or 6.3 mg steps at weekly intervals. The maximum dose is 18.8 mg daily for children 6 to 12, and 12.5 mg daily for adolescents 13 to 17.

How do you take an orally disintegrating tablet?

The tablet stays in its blister pack until the moment it’s needed. With dry hands, it gets removed by tearing along the perforation and peeling back the backing — never pushed through the foil — then placed directly on the tongue, where it dissolves without chewing or crushing.

Why is the maximum dose lower for teens than younger children?

This reflects the specific dosing studied in clinical trials for each age group rather than a general rule about amphetamine tolerance. A prescriber follows the age-specific maximum established for Adzenys XR-ODT, which is 18.8 mg for ages 6 to 12 and 12.5 mg for ages 13 to 17.

Can Adzenys XR-ODT be taken with food?

Yes, it can be taken with or without food, based on what works best for the patient.

What happens if a dose is missed?

If a morning dose is missed, it generally shouldn’t be taken later in the day, since doing so raises the risk of insomnia. Patients should skip the missed dose and resume their normal schedule the next day.

Can Adzenys XR-ODT be swallowed instead of dissolved?

The tablet is specifically designed to dissolve in saliva on the tongue rather than being swallowed whole like a standard tablet. Patients who need a different administration method should discuss alternatives, such as a capsule-based extended-release product, with their prescriber.

What are the most common side effects of Adzenys XR-ODT?

The most frequently reported side effects include decreased appetite, insomnia, weight loss, headache, irritability, and dry mouth. Most side effects are mild, but anything severe or persistent should be reported to a prescriber.

Is Adzenys XR-ODT addictive?

Yes. Adzenys XR-ODT carries an FDA boxed warning for abuse, misuse, and addiction because it is a Schedule II controlled substance. Even when taken exactly as prescribed, long-term use can lead to physical dependence. Patients should never share their medication, and prescribers routinely reassess abuse risk throughout treatment.

Can Adzenys XR-ODT interact with other medications?

Yes. Combining it with MAOIs is strictly contraindicated due to the risk of hypertensive crisis, and combining it with serotonergic medications or tricyclic antidepressants raises the risk of serotonin syndrome. Patients should disclose every medication and supplement to their prescriber before starting treatment.

Is Adzenys XR-ODT safe during pregnancy or breastfeeding?

Decades of data haven’t identified a clear risk of major birth defects during pregnancy, though amphetamines can affect placental blood flow and carry a risk of neonatal withdrawal symptoms. For breastfeeding, the current label specifically recommends against it, given amphetamine’s presence in breast milk and the potential for serious effects in a nursing infant.

Can adults take Adzenys XR-ODT?

The label doesn’t specify an upper age limit, but Adzenys XR-ODT hasn’t been studied in the geriatric population specifically, so prescribers use general clinical judgment and caution when treating older adults.

Can someone switch from Adderall XR to Adzenys XR-ODT?

Yes, patients stabilized on Adderall XR can switch to an equivalent dose of Adzenys XR-ODT using a conversion reference in the prescribing information, since the two products’ milligram strengths don’t match directly. A prescriber should manage this switch rather than a patient estimating the equivalent dose independently.

What should I do if I think I’ve taken too much Adzenys XR-ODT?

Suspected overdose is a medical emergency. Symptoms can include a rapid heartbeat, dangerously high body temperature, severe agitation, hallucinations, or seizures. Call Poison Control at 1-800-222-1222 or go to the nearest emergency room immediately rather than waiting to see if symptoms improve.

Conclusion

Adzenys XR-ODT takes a well-established stimulant and delivers it through a genuinely different route — dissolving on the tongue rather than requiring a swallowed capsule — which solves a real, common problem for patients who struggle with traditional pill-taking. That different delivery method comes with its own quirks worth understanding: a distinct measurement system based on amphetamine base rather than salt weight, and specific handling instructions for the blister packaging. Beyond those differences, Adzenys XR-ODT carries the same class-wide warnings around cardiovascular risk, psychiatric symptoms, and abuse potential shared by other amphetamine products.